Anchor Investment Management, LLC Crispr Therapeutics Ag Transaction History

Anchor Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jan 02, 2024	SELL	$41.0 - $56.12 $1,640 - $2,244	-40 Closed	0 $0
Q4 2022 Jan 02, 2024	BUY	$39.19 - $65.67 $1,567 - $2,626	40 New	40 $1.63 Million
Q3 2022 Jan 02, 2024	BUY	$61.1 - $83.78 $8,554 - $11,729	140 New	140 $9.15 Million
Q4 2021 Jan 02, 2024	BUY	$70.09 - $111.29 $7,009 - $11,129	100 Added 250.0%	140 $10.6 Million
Q3 2021 Jan 02, 2024	BUY	$110.2 - $156.64 $4,408 - $6,265	40 New	40 $4.48 Million
Q3 2020 Jan 02, 2024	BUY	$78.5 - $100.64 $3,140 - $4,025	40 New	40 $3.35 Million
Q2 2020 Jan 02, 2024	BUY	$38.5 - $76.05 $1,540 - $3,042	40 New	40 $2.94 Million

485

57.5M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anchor Investment Management, LLC with notifications on news.